NeoGenomics Inc. Common Stock vs Stellantis N.V. Common Shares — how do they compare? NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.17B), while Stellantis N.V. Common Shares trades at $4.27 (market cap $16.20B). The key difference: Stellantis N.V. Common Shares is far larger — about 7.5× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, Stellantis N.V. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Stellantis N.V. Common Shares for 0 Days on average.
| NEO | STLA | |
|---|---|---|
Market Cap | $2.17B | $16.20B |
Volume | 1,615,943 | 30,607,418 |
Sector | Health | Consumer Cyclical |
52-Week High | $19.91 | $12.12 |
52-Week Low | $7.19 | $4.27 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.47B | $35.94B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.
Read more on STLA →